Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 28, 2017OncoImmunologyOpen Access

Molecular and clinical characterization of TIM-3 in glioma through 1,024 samples

View Full Paper
Ask AI
Bookmark
Share

Authors

GLGuanzhang LiBeijing Institute of NeurosurgeryZWZheng WangHebei Medical UniversityCZChuanbao ZhangCapital University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Li et al. (2017) studied this question.

synapsesocial.com/papers/69d78120f07a12db70b8b215https://doi.org/10.1080/2162402x.2017.1328339
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Tim-3: An Emerging Target in the Cancer Immunotherapy Landscape2014 · 309 citations
  2. 2IDH1 and IDH2 Mutations in Gliomas2009 · 6,014 citations
  3. 3Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain glioma2016 · 206 citations